Schonfeld Strategic Advisors LLC Abb Vie Inc. Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 13,748 shares of ABBV stock, worth $2.47 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

13,748

Previous 8,685 58.3%

Holding current value

$2.47 Million

Previous $1.49 Million 82.27%

% of portfolio

0.02%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $829,521 - $1.01 Million	5,063 Added 58.3%	13,748 $2.71 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $858,310 - $1 Million	5,545 Added 176.59%	8,685 $1.49 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $501,834 - $571,794	3,140 New	3,140 $571,000
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $432,163 - $500,292	3,235 Added 195.47%	4,890 $728,000
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $7.71 Million - $9.6 Million	-58,209 Reduced 97.24%	1,655 $222,000
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $139,404 - $160,544	964 Added 1.64%	59,864 $9.54 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $1.83 Million - $2.2 Million	-13,260 Reduced 18.38%	58,900 $9.52 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $9.45 Million - $10.8 Million	70,396 Added 3990.7%	72,160 $9.68 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $445,338 - $566,170	-3,236 Reduced 64.72%	1,764 $271,000
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $2.96 Million - $3.68 Million	-22,465 Reduced 81.8%	5,000 $810,000
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $3.18 Million - $4.03 Million	-29,614 Reduced 51.88%	27,465 $3.72 Million
Q3 2021 Nov 16, 2021	SELL	$106.4 - $120.78 $5.55 Million - $6.3 Million	-52,126 Reduced 47.73%	57,079 $6.16 Million
Q2 2021 Nov 16, 2021	SELL	$105.21 - $117.21 $357,714 - $398,514	-3,400 Reduced 3.02%	109,205 $12.3 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $5.71 Million - $6.36 Million	54,285 Added 93.08%	112,605 $12.7 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $1.66 Million - $1.82 Million	16,192 Added 38.44%	58,320 $6.31 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $1.69 Million - $2.28 Million	-20,944 Reduced 33.21%	42,128 $4.51 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $3.25 Million - $3.82 Million	37,867 Added 150.24%	63,072 $6,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $201,327 - $269,405	2,744 Added 12.22%	25,205 $2.47 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $1.45 Million - $2.2 Million	22,461 New	22,461 $1.71 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $5.58 Million - $6.98 Million	-77,300 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $32,182 - $38,692	-511 Reduced 0.66%	77,300 $5.85 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $4.19 Million - $5.35 Million	63,735 Added 452.79%	77,811 $5.66 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $1.09 Million - $1.28 Million	14,076 New	14,076 $1.13 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $1.51 Million - $1.68 Million	-16,980 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $3.77 Million - $4.46 Million	-41,994 Reduced 71.21%	16,980 $1.57 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $812,908 - $1.09 Million	8,835 Added 17.62%	58,974 $5.58 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $3.68 Million - $4.04 Million	41,139 Added 457.1%	50,139 $4.85 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $628,650 - $802,980	9,000	9,000 $800,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Abb Vie Inc. Transaction History